# Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

> **NCT04193852** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 10 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug
- **DRUG:** Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Reference Product

## Key facts

- **NCT ID:** NCT04193852
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-09
- **Primary completion:** 2019-11-12
- **Final completion:** 2019-11-25
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04193852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04193852, "Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04193852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*